These results demonstrated that Yam Gruel may be a potential diet therapy for improving lipid metabolism in T2DM patients and that it may exert its effects via AMPK/ACC/CPT-1 pathway activation. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.